About This Stock More About This StockReadReadReadRead
Article By: Leigh Drogen
Tuesday, February 7, 2017 10:38 AM EDT
Besides the question of drug sales, Gilead faces the threat of a drug pricing intervention. Any indication that financial performance will be hurt in fiscal 2017 from the new administration could ignite a sharp sell off.